Research We Fund

Your generous support enables us to fund millions of dollars in research every year, in locations across the globe. We fund projects across the research pipeline, from basic research through clinical trials, and our support has led to several potential treatments currently in clinical trials. 


ALS United, along with its dedicated members, has taken a significant step in the battle against Amyotrophic Lateral Sclerosis (ALS) by collectively supporting the Accelerating Medicines Partnership (AMP) ALS initiative.  This groundbreaking project aims to expedite the development of effective treatments for ALS, providing hope and progress for those affected by this relentless disease. 

The AMP ALS initiative is designed to address the critical challenges faced in ALS research, including disease heterogeneity, segmented research efforts, and the need for standardized tools. By establishing a central ALS Knowledge Platform and validating biomarkers, AMP ALS aims to improve clinical outcome assessments and discover new therapeutic targets. The initiative's comprehensive approach promises to accelerate the development of life-saving therapies and improve patient outcomes.